TCL Archive ACS-Led National Cancer Dialogue Beset By Patient Mistrust, Lack Of Openness January 21, 2000
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Cancer Research Emphasis Grants (CREG) Offered As A New Way To Fund Contract Research Efforts November 23, 1974
